Evaluating the effectiveness, impact and safety of live attenuated and seasonal inactivated influenza vaccination: protocol for the Seasonal Influenza Vaccination Effectiveness II (SIVE II) study

INTRODUCTION: Seasonal (inactivated) influenza vaccination is recommended for all individuals aged 65+ and in individuals under 65 who are at an increased risk of complications of influenza infection, for example, people with asthma. Live attenuated influenza vaccine (LAIV) was recommended for child...

Descripción completa

Detalles Bibliográficos
Autores principales: Simpson, Colin R, Lone, Nazir I, Kavanagh, Kimberley, Robertson, Chris, McMenamin, Jim, von Wissmann, Beatrix, Vasileiou, Eleftheria, Butler, Chris, Ritchie, Lewis D, Gunson, Rory, Schwarze, Jürgen, Sheikh, Aziz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Health Services Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337698/
https://www.ncbi.nlm.nih.gov/pubmed/28246142
http://dx.doi.org/10.1136/bmjopen-2016-014200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337698/
https://www.ncbi.nlm.nih.gov/pubmed/28246142
http://dx.doi.org/10.1136/bmjopen-2016-014200

Ejemplares similares